ICL-CCIC-0019
ICL-CCIC-0019 is an inhibitor of choline kinase α (CHKα) . ICL-CCIC-0019 induces G1 block, endoplasmic reticulum stress apoptosis in cancer cell lines[1].
Product Specifications
CAS Number
936498-64-5
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/icl-ccic-0019.html
Purity
97.80
Solubility
DMSO : 8.33 mg/mL (ultrasonic)
Smiles
CN(C)C1=CC=[N+](C=C1)CCCCCCCCCCCC[N+]2=CC=C(C=C2)N(C)C.[Br-].[Br-]
Molecular Formula
C26H44Br2N4
Molecular Weight
572.46
References & Citations
[1]Trousil S, et al. The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth. Oncotarget. 2016 Jun 14;7 (24) :37103-37120.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB0718-100 1x 100 µL
HER-2 / CD340 (HRB2/718), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
F-2102-2 1 mg
FITC Conjugated Succinyl Triticum vulgare Lectin (Wheat Germ)-Succinyl WGA-
Sign In for Pricing
View Details 
BNC040823-100 1x 100 µL
P21 / WAF1 (CIP1/823), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details